Letter to BS: The idea of technologically enhancing our bodies is not new

The science of extending life has been a subject of fascination down the centuries including the biblical Methuselah

Image via Shutterstock
Image via Shutterstock
Business Standard
2 min read Last Updated : Sep 29 2019 | 11:35 PM IST
This refers to “Understanding the process of ageing” by Devangshu Datta (September 27). The standards in modern medicine are allowing us to live longer than ever before. The interest is not in extending life by days or weeks, but by decades and even centuries. Mortality will then be optional. 

The science of extending life has been a subject of fascination down the centuries including the biblical Methuselah. Old billionaires being cryogenically frozen is not a fantasy any longer with many options available now to freeze our bodies with the hope that some time in future, science will revive them. Some cynics express that they would rather be buried in a cemetery than in a refrigerator. The Silicon Valley billionaires, venture capitalists and investors including Jeff Bezos, PayPal Co-founder Peter Thiel, Larry Ellison of Oracle, Elon Musk of Tesla and Craig Venter are all interested and pouring money into the science of senolytics — an emerging anti-ageing medicine. 

The idea of technologically enhancing our bodies is not new. Implants like prosthetics and stents have improved our lifespans and in future, may enhance our senses by merging man and machine. Science may then produce humans who have vastly increased intelligence, strength, and lifespan. Some drugs under evaluation are metformin, an old and established diabetes drug. It has become popular among life extensionists and is sometimes referred to as “the aspirin of anti-ageing”. Another potential drug is rapamycin normally used to aid organ transplants and treat rare cancers. Many of the world’s top gerontologists have demonstrated the possibilities in animals and are now beginning human clinical trials. Current recommendation till these pills are in use is a healthy diet by reducing the amount of animal protein one consumes. The association between low protein intake and longevity is well established. Ideally this protein should be from plants.

H N Ramakrishna, Bengaluru Letters can be mailed, faxed or e-mailed to: 
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg 
New Delhi 110 002 
Fax: (011) 23720201  ·  
E-mail: letters@bsmail.in
All letters must have a postal address and telephone number

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :ageing

Next Story